rs78087585
Positions:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_021116.4(ADCY1):c.897C>T(p.His299=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00391 in 1,613,608 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0043 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0039 ( 28 hom. )
Consequence
ADCY1
NM_021116.4 synonymous
NM_021116.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.163
Genes affected
ADCY1 (HGNC:232): (adenylate cyclase 1) This gene encodes a member of the of adenylate cyclase gene family that is primarily expressed in the brain. This protein is regulated by calcium/calmodulin concentration and may be involved in brain development. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 7-45610486-C-T is Benign according to our data. Variant chr7-45610486-C-T is described in ClinVar as [Benign]. Clinvar id is 517530.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-45610486-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.163 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADCY1 | NM_021116.4 | c.897C>T | p.His299= | synonymous_variant | 3/20 | ENST00000297323.12 | |
ADCY1 | NM_001281768.2 | c.222C>T | p.His74= | synonymous_variant | 4/10 | ||
ADCY1 | XM_005249584.4 | c.897C>T | p.His299= | synonymous_variant | 3/19 | ||
ADCY1 | XM_005249585.3 | c.897C>T | p.His299= | synonymous_variant | 3/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADCY1 | ENST00000297323.12 | c.897C>T | p.His299= | synonymous_variant | 3/20 | 1 | NM_021116.4 | P1 | |
ADCY1 | ENST00000432715.5 | c.222C>T | p.His74= | synonymous_variant | 4/10 | 2 | |||
ADCY1 | ENST00000621543.1 | c.222C>T | p.His74= | synonymous_variant | 3/9 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00431 AC: 655AN: 152058Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
655
AN:
152058
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00321 AC: 800AN: 249252Hom.: 7 AF XY: 0.00332 AC XY: 448AN XY: 134928
GnomAD3 exomes
AF:
AC:
800
AN:
249252
Hom.:
AF XY:
AC XY:
448
AN XY:
134928
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00387 AC: 5655AN: 1461432Hom.: 28 Cov.: 31 AF XY: 0.00390 AC XY: 2838AN XY: 727042
GnomAD4 exome
AF:
AC:
5655
AN:
1461432
Hom.:
Cov.:
31
AF XY:
AC XY:
2838
AN XY:
727042
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00433 AC: 659AN: 152176Hom.: 3 Cov.: 32 AF XY: 0.00406 AC XY: 302AN XY: 74402
GnomAD4 genome
AF:
AC:
659
AN:
152176
Hom.:
Cov.:
32
AF XY:
AC XY:
302
AN XY:
74402
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 15, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 23, 2017 | p.His299His in exon 3 of ADCY1: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 0.62% (64/10396) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broad institute.org; dbSNP rs78087585). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at